Abiomed Inc. | Income Statement
Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
183,643.00
230,311.00
329,543.00
445,304.00
593,749.00
769,432
Cost of Goods Sold (COGS) incl. D&A
37,322.00
39,945.00
50,419.00
70,627.00
98,581.00
129,567
Gross Income
146,321.00
190,366.00
279,124.00
374,677.00
495,168.00
639,865
SG&A Expense
131,758.00
160,090.00
212,967.00
282,949.00
336,694.00
415,968
EBIT
14,563.00
30,276.00
66,157.00
91,728.00
158,474.00
223,897
Unusual Expense
6,200.00
1,610.00
1,053.00
1,590.00
1,337.00
32,115
Non Operating Income/Expense
49.00
97.00
339.00
349.00
388.00
818
Pretax Income
8,530.00
28,765.00
65,838.00
91,343.00
160,437.00
263,360
Income Tax
1,179.00
84,923.00
27,691.00
39,227.00
48,267.00
4,344
Consolidated Net Income
7,351.00
113,688.00
38,147.00
52,116.00
112,170.00
259,016
Net Income
7,351.00
113,688.00
38,147.00
52,116.00
112,170.00
259,016
Net Income After Extraordinaries
7,351.00
113,688.00
38,147.00
52,116.00
112,170.00
259,016
Net Income Available to Common
7,351.00
113,688.00
38,147.00
52,116.00
112,170.00
259,016
EPS (Basic)
0.18
2.65
0.85
1.17
2.45
5.61
Basic Shares Outstanding
39,334.00
40,632.00
42,204.00
43,238.00
44,153.00
44,911
EPS (Diluted)
0.18
2.65
0.85
1.17
2.45
5.61
Diluted Shares Outstanding
41,606.00
42,858.00
44,895.00
44,658.00
45,849.00
46,151
EBITDA
17,071.00
33,046.00
69,434.00
97,930.00
169,479.00
238,018
Non-Operating Interest Income
118.00
196.00
395.00
1,554.00
3,688.00
8,166
About Abiomed
View Profile
